DiaMedica Therapeutics (DMAC) Times Interest Earned (2021 - 2026)
DiaMedica Therapeutics filings provide 6 years of Times Interest Earned readings, the most recent being -$455.74 for Q1 2026.
- Quarterly Times Interest Earned rose 94.4% to -$455.74 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1597.2 through Mar 2026, up 73.67% year-over-year, with the annual reading at -$3439.7 for FY2025, 3093.6% down from the prior year.
- Times Interest Earned hit -$455.74 in Q1 2026 for DiaMedica Therapeutics, up from -$8144.0 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.17 in Q4 2022 and bottomed at -$8144.0 in Q1 2025.
- Average Times Interest Earned over 5 years is -$1780.5, with a median of -$302.16 recorded in 2024.
- The largest annual shift saw Times Interest Earned plummeted 2595.28% in 2025 before it skyrocketed 94.4% in 2026.
- DiaMedica Therapeutics' Times Interest Earned stood at -$0.17 in 2022, then fell by 19.36% to -$0.21 in 2023, then tumbled by 144773.55% to -$302.16 in 2024, then plummeted by 2595.28% to -$8144.0 in 2025, then surged by 94.4% to -$455.74 in 2026.
- Per Business Quant, the three most recent readings for DMAC's Times Interest Earned are -$455.74 (Q1 2026), -$8144.0 (Q1 2025), and -$302.16 (Q1 2024).